![\"\"](\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2020\/06\/4000-cb2-insights.jpg\")
<\/p>\n<\/p>\n
CB2 Insights Inc.<\/strong> will be hosting its Q1 2020 earnings call on Wednesday, July 15, 2020 at 9:00 a.m. Eastern Daylight Time (EDT).<\/p>\n CB2 will issue a press release and file its interim financial statements and interim Quarterly Management Discussion and Analysis (“MD&A”) for the quarter ended March 31, 2020 (the “Q1 2020 Filings”) after the close of markets on July 14, 2020.<\/p>\n Conference call details:<\/strong><\/p>\n A replay of the earnings call will be available on the company’s website 24 hours after the call takes place.<\/p>\n Submitting Questions:<\/p>\n Those interested in submitting questions for the earnings call can do so by emailing investors@cb2inisghts.com prior to the start of the call. CB2 Insights will attempt to answer all questions submitted, however some questions may not be answered during the call due to time constraints.<\/p>\n The Company looks forward to providing additional discussion on its Q1 2020 Filings, as well as providing an update on the business and preliminary expectations for Q2 2020. Further, the Company will update shareholders on its future outlook and plans for growth in the coming quarters.<\/p>\n About CB2 Insights<\/strong><\/p>\n CB2 Insights CB2 Insights is a healthcare services and technology company, working to positively impact patient health outcomes. Our mission to mainstream alternative health treatments into traditional healthcare by recognizing the need for patient treatment diversity, and the impacts of integrating alternative and conventional medicine. The Company works primarily to roster and treat patients who are seeking alternative treatments due to the ineffectiveness of conventional medicine, and the inability to find support through their existing care network, or in some cases, inability to access a primary care network. Medical services offered by the Company are defined as Integrative medicine, where we work to understand the real world evidence for the safety, impact and effectiveness of medical treatments including plant based medicines that often lack sufficient research and therefore adoption by conventional healthcare providers.<\/p>\n To support patient care and positive health outcomes, the Company is also focused on advancing safety and efficacy research surrounding alternative health treatments by monitoring and assessing Real-World Data (RWD) and providing Real-World Evidence (RWE) through our proprietary technology, data analytics, and a full service contract research organization.<\/p>\n The Company’s primary operations are in the United States, with application to its insights, technology and research services deployed in other International markets including Canada, United Kingdom and Colombia.<\/p>\n The Company’s disciplined operating model, allows patients to receive access to care in a time efficient and cost-effective manner. Utilizing virtual telehealth and over 30 physical brick and mortar clinics, the Company currently treats over 100,000 patients across 12 States. Utilizing proprietary technology and data analytic platforms, the Company is able to monitor, study and assess a variety of healthcare treatments and products for the safety, efficacy and effectiveness. The Company believes it is well positioned to be the research and technology partner of choice for multiple stakeholders including Big Pharma, Life Sciences, Regulatory Bodies and Payors within the traditional and integrative medical industry.<\/p>\n Tags:<\/b> \u00a0investors@cb2inisghts.com\u00a0<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"\n\n
\n Date:<\/td>\n Wednesday, July 15, 2020<\/td>\n<\/tr>\n \n Time:<\/td>\n 9:00 a.m. (EDT)<\/td>\n<\/tr>\n \n US\/Canada Toll Free Dial In:<\/td>\n 1-800-319-4610<\/td>\n<\/tr>\n \n Toronto Local Dial In:<\/td>\n 1-416-915-3239<\/td>\n<\/tr>\n \n International Dial In:<\/td>\n 1-604-638-5340<\/td>\n<\/tr>\n \n Call Name:<\/td>\n CB2 Insights Earnings Call<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n See Campaign: <\/strong>http:\/\/cb2inisghts.com<\/a>
Contact Information:<\/b>
investors@cb2inisghts.com<\/p>\n
<\/a>, Wire<\/a>, Disclosure Newswire<\/a>, United States<\/a>, English<\/a><\/p>\n<\/div>\n
\nContact Information:<\/h3>\n
CB2 Insights Inc. will be hosting its Q1 2020 earnings call on Wednesday, July 15, 2020 at 9:00 a.m. Eastern Daylight Time (EDT). CB2 will issue a press release and file its interim financial statements and interim Quarterly Management Discussion and Analysis (“MD&A”) for the quarter ended March 31, 2020 (the “Q1 2020 Filings”) after the … Continue reading CB2 Insights to Host Q1 2020 Earnings Call on July 15, 2020<\/span><\/a> Continue Reading